19 November 2014
TWENTYFOUR SELECT MONTHLY INCOME FUND LIMITED
(a closed-ended investment company incorporated in Guernsey with registration
number 57985)
Issue of equity
The board of TwentyFour Select Monthly Income Fund Limited (the "Company",
"SMIF") is pleased to announce that 500,000 new ordinary shares of 1p each were
today issued for cash at 98.51 pence per share (the "New Shares") under the
Placing Programme (as described in the Company's prospectus, dated 18 February
2014).
As a result of the issue of equity set out above, the Company's issued share
capital consists of 130,135,881 Ordinary shares.
Application has been made for the New Shares to be admitted to the premium
segment of the Official List and to trading on the Main Market of the London
Stock Exchange. It is expected that dealings in the new shares will commence at
8.00 a.m. on Friday 21 November 2014.
For further information, please contact:
Numis Securities Limited:
Nathan Brown +44 (0)20 7260 1000
Hugh Jonathan
TwentyFour Select Monthly Income Fund Limited:
John Magrath +44 (0)20 7015 8900
Alistair Wilson
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.